Evidence map›Paper›PMID 26700664›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Akt activation correlates with the tumor aggressiveness in Tunisian patients with bladder cancer.

Islem Ben Bahria-Sediki, Carla Sampaio, Mohamed Chebil, Mohamed Cherif, Rachida Zermani, Soumaya Rammeh, Amel Ben Ammar El Gaaied, Ali Bettaieb

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Islem Ben Bahria-SedikiEPHE, Laboratoire d'Immunologie et Immunothérapie des Cancers, Paris, F-75014, France.
Carla SampaioEPHE, Laboratoire d'Immunologie et Immunothérapie des Cancers, Paris, F-75014, France.
Mohamed ChebilHôpital Charles Nicolle de Tunis, Tunis, Tunisia.
Mohamed CherifHôpital Charles Nicolle de Tunis, Tunis, Tunisia.
Rachida ZermaniHôpital Charles Nicolle de Tunis, Tunis, Tunisia.
Soumaya RammehHôpital Charles Nicolle de Tunis, Tunis, Tunisia.
Amel Ben Ammar El GaaiedLaboratoire de Génétique, Immunologie et Pathologies Humaines, Faculté de Sciences Tunis, Université de Tunis El Manar, Tunis, Tunisia. amel.benammarelgaaied@gmail.com.
Ali BettaiebEPHE, Laboratoire d'Immunologie et Immunothérapie des Cancers, Paris, F-75014, France. ali.bettaieb@u-bourgogne.fr.
Hôpital Charles-Nicolle · TNTunis El Manar University · TNUniversité de Bourgogne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various studies in western countries found Akt amplification to be a frequent event in human cancers, including bladder, but the correlation with clinicopathological features is controversial. Such studies have not been reported in African populations, including Tunisians. The purpose of this study was to assess expression of the phosphorylated/activated forms of Akt in tumors from Tunisian patients with bladder cancer and to correlate its expression with pathological and clinical parameters of the disease. The study included 72 patients of whom 34 were diagnosed as low- to medium-grade and 35 as high-grade; 30 were muscle stage and 39 non-muscle stage. Primary tumors from these patients, normal adjacent tissues, or bladder cancer cell-lines were analyzed for Ser473 phosphorylated Akt expression by Western blot. Seventy-two percent of primary tumors from patients with bladder cancer had increased levels of p-Akt. The p-Akt levels in patients with high-grade bladder cancer were significantly elevated compared to patients with low- or medium-grade bladder cancer. In invasive carcinoma, the p-Akt level was significantly higher than in superficial non-invasive bladder tumors. Concerning the influence of tobacco on Akt activation, no significant differences of p-Akt expression were found between non-smoker and smoker patients. Altogether, our results suggest that Akt activation can provide useful prognostic information and that tobacco represents a serious risk factor for recurrence in a cohort of Tunisian patients.

Indexed as

AdultAgedAged, 80 and overBlack PeopleBlotting, WesternCell Line, TumorCell SurvivalFemaleHumansMaleMiddle AgedNeoplasm StagingPhosphorylationPrognosisProto-Oncogene Proteins c-aktTunisiaProto-Oncogene Proteins c-aktAktBladder carcinomaPrognosisTobacco

Identifiers

PMID26700664
OpenAlexW2199421205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.